|
WIPF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.08080000000588E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.017800E-04 |
| Normal-vs-Stage2 |
2.166200E-02 |
| Normal-vs-Stage3 |
4.80629999999316E-06 |
| Normal-vs-Stage4 |
1.7172299999979E-05 |
| Stage1-vs-Stage2 |
5.458400E-01 |
| Stage1-vs-Stage3 |
1.333010E-01 |
| Stage1-vs-Stage4 |
7.390100E-02 |
| Stage2-vs-Stage3 |
9.915900E-02 |
| Stage2-vs-Stage4 |
6.703900E-02 |
| Stage3-vs-Stage4 |
6.995600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.9211000000039E-05 |
| Normal-vs-AfricanAmerican |
1.362850E-01 |
| Normal-vs-Asian |
2.342700E-03 |
| Caucasian-vs-AfricanAmerican |
2.075800E-01 |
| Caucasian-vs-Asian |
9.087200E-01 |
| AfricanAmerican-vs-Asian |
3.114600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.16060000013796E-07 |
| Normal-vs-Female |
3.781300E-04 |
| Male-vs-Female |
5.008100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.496700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.004300E-04 |
| Normal-vs-Age(61-80Yrs) |
3.18799999998731E-06 |
| Normal-vs-Age(81-100Yrs) |
5.137900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.057600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.960300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.321800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.190400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.395400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.269600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.483400E-03 |
| Classical-VS-Follicular |
2.662000E-02 |
| Classical-VS-Other |
6.744200E-02 |
| Classical-VS-Normal |
1.817820E-03 |
| Tall-VS-Follicular |
3.853400E-01 |
| Tall-VS-Other |
4.329000E-01 |
| Tall-VS-Normal |
2.32319999999842E-05 |
| Follicular-VS-Other |
3.153600E-01 |
| Follicular-VS-Normal |
5.87359999999482E-05 |
| Other-VS-Normal |
3.415800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.804760E-04 |
| Normal-vs-N1 |
1.96988999999759E-05 |
| N0-vs-N1 |
1.476440E-01 |
|
|
